A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients
Clinical trial NCT07260305 · RECRUITING
Trial details
- NCT number
- NCT07260305
- Sponsor
- Kangabio AUSTRALIA LTD PTY
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-27
- Primary completion
- 2027-01-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.